advertisement
BMJ open 58
Showing records 1 to 25 | Display all abstracts in BMJ open126466 Seizing the silent vision loss: cost-utility analysis of population-based glaucoma screening in India
Purohit N
BMJ open 2025; 15: e098113
126848 Protocol for a systematic review and network meta-analysis comparing the efficacy and safety of benzalkonium chloride-preserved, alternatively preserved and preservative-free eyedrops in the treatment of glaucoma
Kim M
BMJ open 2025; 15: e085303
125632 Prevalence of cataract and its associated factors among adults aged 40 years and above living in Durame town, Southern Ethiopia, 2023: a community-based cross-sectional study
Latebo AA
BMJ open 2024; 14: e089741
126416 Social, personal and medical factors influencing treatment delay for patients with primary glaucoma during the COVID-19 pandemic: a qualitative interview study
Liu H
BMJ open 2025; 15: e096469
124954 Exploring risk factors for comorbid depression in osteoarthritis: a scoping review protocol
Bogensberger KM
BMJ open 2025; 15: e093353
126301 Adaptive coping mechanisms use and associated factors among adult glaucoma patients attending the University of Gondar Comprehensive Specialized Hospital, Tertiary Eye Care and Training Center, Northwest Ethiopia: an institution-based cross-sectional stud
Geremew BM
BMJ open 2025; 15: e086581
126787 Vision Restoration through transorbital electrical stimulation in Optic Neuropathy in patients with significant optic atrophy due to primary open-angle glaucoma-a randomised, controlled, double-blind, multicentre clinical trial: the VIRON study protocol
Schittkowski M
BMJ open 2025; 15: e091705
126081 Characteristics and publication status of minimally invasive glaucoma surgery trials registered in ClinicalTrials.gov, 2007-2024: a cross-sectional study
Peng C
BMJ open 2025; 15: e095854
126848 Protocol for a systematic review and network meta-analysis comparing the efficacy and safety of benzalkonium chloride-preserved, alternatively preserved and preservative-free eyedrops in the treatment of glaucoma
Kim YK
BMJ open 2025; 15: e085303
125632 Prevalence of cataract and its associated factors among adults aged 40 years and above living in Durame town, Southern Ethiopia, 2023: a community-based cross-sectional study
Assefa NL
BMJ open 2024; 14: e089741
126416 Social, personal and medical factors influencing treatment delay for patients with primary glaucoma during the COVID-19 pandemic: a qualitative interview study
Sun L
BMJ open 2025; 15: e096469
124954 Exploring risk factors for comorbid depression in osteoarthritis: a scoping review protocol
Schaffler-Schaden D
BMJ open 2025; 15: e093353
126301 Adaptive coping mechanisms use and associated factors among adult glaucoma patients attending the University of Gondar Comprehensive Specialized Hospital, Tertiary Eye Care and Training Center, Northwest Ethiopia: an institution-based cross-sectional stud
Sisay ML
BMJ open 2025; 15: e086581
126787 Vision Restoration through transorbital electrical stimulation in Optic Neuropathy in patients with significant optic atrophy due to primary open-angle glaucoma-a randomised, controlled, double-blind, multicentre clinical trial: the VIRON study protocol
Pohlner J
BMJ open 2025; 15: e091705
126081 Characteristics and publication status of minimally invasive glaucoma surgery trials registered in ClinicalTrials.gov, 2007-2024: a cross-sectional study
Jia H
BMJ open 2025; 15: e095854
126466 Seizing the silent vision loss: cost-utility analysis of population-based glaucoma screening in India
Buttan S
BMJ open 2025; 15: e098113
124954 Exploring risk factors for comorbid depression in osteoarthritis: a scoping review protocol
Perl E
BMJ open 2025; 15: e093353
126301 Adaptive coping mechanisms use and associated factors among adult glaucoma patients attending the University of Gondar Comprehensive Specialized Hospital, Tertiary Eye Care and Training Center, Northwest Ethiopia: an institution-based cross-sectional stud
Alemayehu BF
BMJ open 2025; 15: e086581
126787 Vision Restoration through transorbital electrical stimulation in Optic Neuropathy in patients with significant optic atrophy due to primary open-angle glaucoma-a randomised, controlled, double-blind, multicentre clinical trial: the VIRON study protocol
Mercieca K
BMJ open 2025; 15: e091705
126081 Characteristics and publication status of minimally invasive glaucoma surgery trials registered in ClinicalTrials.gov, 2007-2024: a cross-sectional study
Hu J
BMJ open 2025; 15: e095854
126466 Seizing the silent vision loss: cost-utility analysis of population-based glaucoma screening in India
Gupta PC
BMJ open 2025; 15: e098113
126848 Protocol for a systematic review and network meta-analysis comparing the efficacy and safety of benzalkonium chloride-preserved, alternatively preserved and preservative-free eyedrops in the treatment of glaucoma
Rho S
BMJ open 2025; 15: e085303
125632 Prevalence of cataract and its associated factors among adults aged 40 years and above living in Durame town, Southern Ethiopia, 2023: a community-based cross-sectional study
Ferede TW
BMJ open 2024; 14: e089741
126416 Social, personal and medical factors influencing treatment delay for patients with primary glaucoma during the COVID-19 pandemic: a qualitative interview study
Li Y
BMJ open 2025; 15: e096469
126466 Seizing the silent vision loss: cost-utility analysis of population-based glaucoma screening in India
Choudhury RK
BMJ open 2025; 15: e098113
